TheraRadar
Company Portfolios →

Boehringer Ingelheim

82 active trials across 13 therapeutic areas

82
Active Trials
43
Phase 1
19
Phase 2
21
Phase 3
13
Therapeutic Areas
Portfolio Concentration: 55% of active trials in Oncology

Oncology

45 active / 109 total
Solid Tumor (Advanced)
13 active
43 total since 2015
SCLC
7 active 1 Ph3
7 total since 2015
Head and Neck Cancer
4 active
4 total since 2015
NSCLC
3 active 1 Ph3
14 total since 2015
Colorectal Cancer
3 active
5 total since 2015
Pancreatic Cancer
3 active
4 total since 2015
Lung Cancer (General)
3 active 1 Ph3
4 total since 2015
Melanoma
2 active
2 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Ovarian Cancer
1 active
1 total since 2015
Brain Tumor
1 active
1 total since 2015
Hepatocellular Carcinoma
1 active
1 total since 2015
Breast Cancer
1 active
1 total since 2015
Gastric Cancer
1 active
1 total since 2015
Esophageal Cancer
1 active
1 total since 2015
Sarcoma
0 active
4 total since 2015
Hematologic Malignancies
0 active
4 total since 2015
Cholangiocarcinoma
0 active
2 total since 2015
MDS
0 active
2 total since 2015
Non-Hodgkin Lymphoma
0 active
2 total since 2015
Neuroendocrine Tumors
0 active
1 total since 2015
Bladder Cancer
0 active
1 total since 2015
Glioblastoma
0 active
1 total since 2015
Multiple Myeloma
0 active
1 total since 2015
Squamous Cell Carcinoma
0 active
1 total since 2015

Immunology

21 active / 74 total
Ankylosing Spondylitis
13 active 8 Ph3
36 total since 2015
Rheumatoid Arthritis
4 active
13 total since 2015
Psoriasis
2 active
14 total since 2015
Lupus
1 active
4 total since 2015
Ulcerative Colitis
1 active
1 total since 2015
Crohn's Disease
0 active
4 total since 2015
Atopic Dermatitis
0 active
2 total since 2015

Metabolic

9 active / 47 total
Obesity
6 active 2 Ph3
21 total since 2015
Type 2 Diabetes
2 active 2 Ph3
13 total since 2015
Diabetic Complications
1 active
4 total since 2015
NASH/NAFLD
0 active
5 total since 2015
Type 1 Diabetes
0 active
4 total since 2015

Cardiovascular

6 active / 23 total
Heart Failure
2 active 2 Ph3
8 total since 2015
Myocardial Infarction
2 active 2 Ph3
7 total since 2015
Hypertension
1 active 1 Ph3
4 total since 2015
Stroke
1 active 1 Ph3
3 total since 2015
Atrial Fibrillation
0 active
1 total since 2015

Respiratory

5 active / 35 total
Idiopathic Pulmonary Fibrosis
4 active 2 Ph3
15 total since 2015
Cystic Fibrosis
1 active
6 total since 2015
COPD
0 active
12 total since 2015
Asthma
0 active
2 total since 2015

CNS

2 active / 22 total
Opioid Use Disorder
1 active
1 total since 2015
ADHD
1 active
1 total since 2015
Schizophrenia
0 active
8 total since 2015
Major Depression
0 active
6 total since 2015
Alzheimer's Disease
0 active
4 total since 2015
PTSD
0 active
1 total since 2015
Parkinson's Disease
0 active
1 total since 2015

Renal

2 active / 6 total
Chronic Kidney Disease
2 active 1 Ph3
6 total since 2015

Hepatology

1 active / 3 total
Cirrhosis
1 active
3 total since 2015

Urology

1 active / 3 total
Erectile Dysfunction
1 active
3 total since 2015

Ophthalmology

1 active / 3 total
Age-Related Macular Degeneration
1 active
3 total since 2015

Gastrointestinal

0 active / 4 total
Peptic Ulcer
0 active
4 total since 2015

Pain

0 active / 4 total
Acute Pain
0 active
4 total since 2015

Infectious Disease

0 active / 3 total
COVID-19
0 active
3 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)